Session information

Symposium

[SY22] Symposium 22　Future challenge of liquid biopsy for next generation cancer therapeutics
【E】

Fri. Feb 18, 2022 3:05 PM - 4:35 PM Room 11 and 12 (Prince Hall 1 and 2, B2F, The Prince Kyoto Takaragaike)

Chair：Maki Tanioka（Department of Medical AI, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences），Antoine Italiano（Head of Precision Medicine Program Gustave Roussy Campus, Villejuif, France）

+Add all to schedule

[SY22-1] Assign optimal roles between plasma-derived or tumor-derived gene panel

^○Koshi Mimori (Department of Surgery, Kyushu University Beppu Hospital)

[SY22-2] Clinical relevance of comprehensive genomic profiling for hematologic malignancies

^○Keisuke Kataoka (Division of Hematology, Department of Medicine, Keio University School of Medicine)

[SY22-3] Implementing ctDNA next-generation sequencing with a large panel in a precision medicine program: clinical impact for patient management

^○Italiano Antoine (Head of Precision Medicine Program Gustave Roussy Campus, Villejuif, France)

[SY22-4] Current and Future Paradigms of Liquid Biopsy for Cancer Care

^○Yoshiaki Nakamura (National Cancer Center Hospital East)

▲